[2P-379] Development of pyrazolopyridine derivatives as novel PPAR alpha activators for metabolic diseases

^○Keisuke Tachibana¹, Syohei FUKUDA¹, Tomohiro YUZURIHA^1,2, Ryotaro TABATA¹, Kazuto NUNOMURA¹, Bangzhong LIN¹, Tadayuki KOBAYASHI¹, Kenji ISHIMOTO¹, Hiroyuki MIYACHI³, Takefumi DOI¹ (1.Graduate School of Pharmaceutical Sciences, Osaka University, 2.Faculty of Pharmaceutical Sciences, Setsunan University, 3.Lead Exploration Unit, Drug Discovery Initiative, The University of Tokyo)

キーテクノロジー：PPARαリガンドスクリーニング系

PPARα活性化剤、ピラゾロピリジン誘導体、スクリーニング、生活習慣病